X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-18
ADCOCK INGRAM
Jun-14
ALEMBIC PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs645365-   
Low Rs470264-   
Sales per share (Unadj.) Rs166.1108.7-  
Earnings per share (Unadj.) Rs21.9-27.4-  
Cash flow per share (Unadj.) Rs27.5-22.7-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs117.885.3-  
Shares outstanding (eoy) m188.52168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.9 116.0%   
Avg P/E ratio x25.5-11.5 -221.7%  
P/CF ratio (eoy) x20.3-13.9 -146.3%  
Price / Book Value ratio x4.73.7 128.4%  
Dividend payout %18.30-   
Avg Mkt Cap Rs m105,09053,081 198.0%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m6,2283,331 186.9%   
Avg. sales/employee Rs ThNM4,273.4-  
Avg. wages/employee Rs ThNM776.0-  
Avg. net profit/employee Rs ThNM-1,076.8-  
INCOME DATA
Net Sales Rs m31,30818,346 170.7%  
Other income Rs m70128 54.7%   
Total revenues Rs m31,37818,474 169.9%   
Gross profit Rs m6,431-3,179 -202.3%  
Depreciation Rs m1,055792 133.2%   
Interest Rs m34497 6.8%   
Profit before tax Rs m5,413-4,339 -124.7%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m-810-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,204271 443.8%   
Profit after tax Rs m4,128-4,623 -89.3%  
Gross profit margin %20.5-17.3 -118.5%  
Effective tax rate %22.2-6.2 -355.8%   
Net profit margin %13.2-25.2 -52.3%  
BALANCE SHEET DATA
Current assets Rs m18,24713,437 135.8%   
Current liabilities Rs m11,2357,560 148.6%   
Net working cap to sales %22.432.0 69.9%  
Current ratio x1.61.8 91.4%  
Inventory Days Days86111 77.2%  
Debtors Days Days61124 49.5%  
Net fixed assets Rs m20,0357,832 255.8%   
Share capital Rs m37785 442.6%   
"Free" reserves Rs m21,8240-   
Net worth Rs m22,20114,399 154.2%   
Long term debt Rs m5,0005,060 98.8%   
Total assets Rs m39,41127,201 144.9%  
Interest coverage x160.2-7.7 -2,071.8%   
Debt to equity ratio x0.20.4 64.1%  
Sales to assets ratio x0.80.7 117.8%   
Return on assets %10.6-15.2 -69.6%  
Return on equity %18.6-32.1 -57.9%  
Return on capital %19.7-19.8 -99.6%  
Exports to sales %46.40-   
Imports to sales %10.50-   
Net fx Rs m7,6960-   
CASH FLOW
From Operations Rs m3,1241,566 199.5%  
From Investments Rs m-8,844-481 1,839.3%  
From Financial Activity Rs m5,0264,592 109.4%  
Net Cashflow Rs m-6935,678 -12.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.04 Rs / ZAR

Compare ALEMBIC PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: AJANTA PHARMA  SUN PHARMA  ORCHID PHARMA LTD  UNICHEM LAB  BIOCON LTD  



Today's Market

Sensex Ends 331 Points Higher; Oil & Gas Stocks Witness Buying(Closing)

After opening on a negative note, share markets in India witnessed buying interest during closing hours and ended the day on a positive note.

Related Views On News

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 42.6% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, ALEMBIC PHARMA has posted a net profit of Rs 904 m (up 42.6% YoY). Sales on the other hand came in at Rs 9 bn (up 33.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Nov 13, 2018 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - J.B.CHEMICALS COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS